Market Recap — May 5, 2026
Recap of insider activity, SEC filings, and market-moving news for May 5, 2026.
Last generated Jul 11, 2026, 4:27 AM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
RenX Seeks Shareholder Approval for Over 8000% Potential Dilution from Recent Financings and Another Reverse Stock Split to Maintain Nasdaq Listing
ChronoScale Corporation Finalizes Business Combination, Secures $15.75M PIPE, and Reconstitutes Board
First Seacoast Bancorp Announces Definitive Merger Agreement with Cambridge Financial Group
First Seacoast Bancorp to be Acquired by Cambridge Financial Group in All-Cash $80.9M Merger at $17.25/Share
First Seacoast Bancorp to Merge with Cambridge Financial for $17.25 Cash Per Share
Shareholders Approve $21.00/Share Cash Merger; Closing Expected May 6, 2026
Dianthus Therapeutics Secures $777.7M in Capital, Extends Runway to 2030, and Receives Orphan Drug Designation
Avanos Medical to be Acquired for $25.00/Share in Definitive Merger Agreement
Bullish to Acquire Equiniti for $4.2 Billion, Targeting Global Tokenization Leadership
SmartKem Seeks Shareholder Approval for Massive Dilution, Reverse Stock Splits, and $500M Equity Line to Address Financial Distress
Scilex Subsidiary Sells ACEA Pharma for $1 Billion Stake in Phoenix Asia, Creating New Public Entity
Scilex Subsidiary Sells ACEA Pharma for $1B in Phoenix Shares, Gains 82% Stake in Nasdaq-Bound Entity
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Sponsor Commits $3.55M in Private Placement Units Alongside IPO
Director & 10% Owner Marshall T. Reynolds Buys Nearly $1M in FGBI Stock, Reinforcing Insider Confidence
Clorox Director Buys $429K in Stock Near 52-Week Lows Amidst Recent Financial Headwinds
10% Owner Mountain Crest Holdings 6 LLC Buys $250K in Units Following IPO Close
CEO/CFO Suying Liu Buys $250K in Mountain Crest Acquisition 6 Shares Post-IPO
AI Era President Buys $111K in Stock, Boosting Holdings Amidst Convertible Note Financing
CFO Purchases $49,920 in Company Stock Following Compensation Award
CEO Ajay Amlani Buys $34.5K in AWRE Stock Amidst Recent Losses
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
Director Sells Over $61 Million in FTAI Aviation Stock
Executive Chairman Sells Over $21.5 Million in Company Stock
Director Sells $13.1M in Shares to Company's Ongoing Repurchase Program
CEO Christopher Pappas Sells $9.75 Million in Company Stock
General Counsel Sells $6.7 Million in AAMI Stock Near 52-Week High
CEO Sells Over $912K in Company Stock Following Option Exercise
CEO Sells Over $557K in Company Stock Following Recent Positive News
10% Owner Sells Over $530K in Clene Inc. Stock Amidst Positive FDA News and Public Offering
CEO Sells $396K in Open Market, Liquidating Nearly All Direct Holdings
CEO Sells $215K in Shares Amidst Company Stock Repurchase Program
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
First Seacoast Bancorp to Merge with Cambridge Financial for $17.25 Cash Per Share
Scilex Subsidiary Sells ACEA Pharma for $1 Billion Stake in Phoenix Asia, Creating New Public Entity
Scilex Subsidiary Sells ACEA Pharma for $1B in Phoenix Shares, Gains 82% Stake in Nasdaq-Bound Entity
Farmer Brothers Completes Take-Private Merger with Royal Cup at $1.29/Share; Delisting Imminent
Merck Completes Acquisition of Terns Pharmaceuticals; Shares to Delist
Momentus Forecasts 9X Revenue Growth, Secures $5M Private Placement, and Eliminates All Debt
Digi Power X Lands $1.1 Billion AI Colocation Deal for 40 MW Alabama Data Center
$375M Public Offering Priced at $17.75, Signaling Significant Dilution for Avalo Therapeutics
$36.5M Capital Infusion Secured by Citius Oncology to Accelerate LYMPHIR Launch
Jacobs Lifts 2026 Profit Forecast on Robust AI Infrastructure Demand, Beats Q2 EPS
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
CEO Earl Austin Jr. Files Intent to Sell $123.3M in Company Stock
Knowles Officer & Director Files Intent to Sell $4.75M in Shares Amidst Strong Performance
AIG Files Form 144 to Sell $724.5M in Corebridge Financial Shares
Chairman Files Intent to Sell $2.3M in Shares Amidst Company Buyback Program
Major Shareholder Atlas Venture Files Intent to Sell $28M in Dyne Therapeutics Stock
CEO Christopher Pappas Files Intent to Sell $9.85M in Shares
Officer Files Intent to Sell $5.28M in Shares, Following Recent $3.16M Sale
Former Affiliate Daniel Goldberger Files Intent to Sell $168K in Shares Amid Ongoing Sales
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.